Maze Therapeutics, Inc. (MAZE) ownership: Top institutional holder: Frazier Life Sciences Management, L.P. ($136.33M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4567274.00 | $136.33M | 2026-03-31 |
| TRV GP IV, LLC | 4473958.00 | $133.55M | 2026-03-31 |
| ARCH Venture Management, LLC | 4120053.00 | $122.98M | 2026-03-31 |
| Deep Track Capital, LP | 3477562.00 | $103.81M | 2026-03-31 |
| Jupiter Topco LLC | 3408045.00 | $101.76M | 2026-06-30 |
| JANUS HENDERSON GROUP PLC | 2858876.00 | $85.28M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 2744399.00 | $81.92M | 2026-03-31 |
| BlackRock, Inc. | 2570425.00 | $76.73M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-13 | |
| Sell | null | 2026-08-03 | |
| Sell | null | 2026-08-03 | |
| Sell | null | 2026-08-03 |
Back to MAZE overview · MAZE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.